Planned sale

Danaher Corporation (DHR): Officer filed to sell ~$5.41M

Couchara Georgeann, Officer at Danaher Corporation, filed to sell ~$5.41M of Danaher Corporation shares.

~$5.41M
planned to sell · 23K shares, around Nov 10, 2026
Planned for
Nov 10, 2026
Notice filed
Nov 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 31, 2026CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  2. Sep 2, 2026CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  3. Sep 21, 2026FDAFDA device clearance: Access NT-proBNP
  4. Sep 21, 2026FDARecall: ROTOR ASSY-SW41, Reference Number 331362, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
  5. Sep 21, 2026FDARecall: ROTOR ASSY-SW40, Reference Number 331302, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
  6. Sep 25, 2026FDAFDA device clearance: Xpert Respiratory Panel
  7. Oct 9, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On October 9, 2026, the Board of Directors (the “Board”) of Danaher Corporation (the “Company” or “Danaher”) increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately.”
  8. Oct 19, 2026FDAFDA device clearance: Access MeMed BV
  9. Oct 20, 2026FDAFDA device clearance: Access BNP II
  10. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
  11. Oct 28, 2026Insider · 2 peopleInsiders: 4 sales (~$8.8M)
  12. Oct 30, 2026FDAFDA device clearance: Xpert® Hemorrhagic Fever Panel
  13. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 5.6%
  14. Nov 9, 2026Insider · 2 peopleInsiders: 2 sales (~$4.6M)
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

Explore the data

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data